When a cancer cell leaves the original tumor to spread to a new, faraway location, it first has to survive what most cells ...

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors ...

A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer.

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy ...

A new preclinical study in the journal Signal Transduction and Targeted Therapy describes a very promising therapeutic ...

"The nurse, as I was leaving - I was literally opening the door - said 'oh by the way, and you do know you have prostate ...

Prostate tumors can vanish from the immune system’s radar. Now, scientists have found a way to strip away that disguise by changing the length of a single RNA molecule.

Researchers have developed a fully human antibody that suppressed tumor growth and metastatic spread in preclinical models of ...

A UCLA neurobiology professor and prostate cancer survivor discuss using artificial intelligence to map his disease and inform treatment decisions. Artificial intelligence (AI) has the potential to ...

Reginald Tucker-Seeley, MA, ScM, ScD, concludes the program with advice for caregivers and patients with prostate cancer to maximize the benefit of treatment. This is a synopsis of an Educated Patient ...

Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted treatment option after the FDA cleared capivasertib, sold as Truqap, for use ...

The bill would permanently authorize and expand the Department of Veterans Affairs' precision oncology program.